Walgreens Boots Alliance Inc (NASDAQ:WBA) was the target of a large drop in short interest during the month of September. As of September 14th, there was short interest totalling 25,881,076 shares, a drop of 5.2% from the August 31st total of 27,286,782 shares. Based on an average daily trading volume, of 4,659,390 shares, the days-to-cover ratio is presently 5.6 days. Currently, 3.1% of the company’s stock are short sold.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the transaction, the director now owns 10,943 shares of the company’s stock, valued at approximately $722,128.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ornella Barra purchased 1,700,000 shares of the stock in a transaction on Monday, July 16th. The shares were bought at an average cost of $65.15 per share, for a total transaction of $110,755,000.00. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sei Investments Co. boosted its stake in Walgreens Boots Alliance by 100.9% in the 2nd quarter. Sei Investments Co. now owns 349,451 shares of the pharmacy operator’s stock valued at $20,970,000 after purchasing an additional 175,551 shares during the period. California Public Employees Retirement System boosted its stake in Walgreens Boots Alliance by 7.7% in the 2nd quarter. California Public Employees Retirement System now owns 2,303,917 shares of the pharmacy operator’s stock valued at $138,270,000 after purchasing an additional 165,048 shares during the period. Schaller Investment Group Inc. bought a new stake in Walgreens Boots Alliance in the 2nd quarter valued at $9,152,000. Schwab Charles Investment Management Inc. boosted its stake in Walgreens Boots Alliance by 4.4% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,563,249 shares of the pharmacy operator’s stock valued at $213,849,000 after purchasing an additional 150,763 shares during the period. Finally, Piedmont Investment Advisors LLC boosted its stake in Walgreens Boots Alliance by 12.7% in the 2nd quarter. Piedmont Investment Advisors LLC now owns 198,734 shares of the pharmacy operator’s stock valued at $11,927,000 after purchasing an additional 22,356 shares during the period. Institutional investors and hedge funds own 61.92% of the company’s stock.

Several research analysts have weighed in on the company. Robert W. Baird lowered Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and set a $80.00 price target on the stock. in a research report on Friday, June 29th. BidaskClub raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Wednesday, September 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research report on Tuesday. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. Finally, Royal Bank of Canada reiterated an “outperform” rating on shares of Walgreens Boots Alliance in a research note on Friday, June 29th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $77.11.

Shares of NASDAQ WBA opened at $73.81 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 12 month low of $59.07 and a 12 month high of $80.68. The company has a market cap of $71.66 billion, a PE ratio of 14.48, a price-to-earnings-growth ratio of 1.10 and a beta of 1.09.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 28th. The pharmacy operator reported $1.53 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.47 by $0.06. The company had revenue of $34.33 billion during the quarter, compared to the consensus estimate of $34.15 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The firm’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.33 EPS. research analysts expect that Walgreens Boots Alliance will post 5.97 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Read More: Trading Strategy

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.